First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
Clinical trial NCT03316521 · COMPLETED
Trial details
- NCT number
- NCT03316521
- Sponsor
- Amyndas Pharmaceuticals S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2017-11-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.